Generex Biotechnology Files Pre-IND Briefing Package with FDA for Ii-Key-SARS-CoV-2 Peptide Vaccine Against the COVID-19 Pandemic

NEXT STORY
Tiziana Life Sciences plc (“Tiziana” or the “Company”) Director Appointment
PREV STORY
Vaxil Provides Pre-Clinical and Business Update
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Olema Oncology Reports First Quarter 2021 Financial Results and Provides Corporate Update

author_avatar
NASDAQ Market News

Portola Pharmaceuticals to Present New Interim Phase 2 Results for Cerdulatinib During an Oral Session at the 60th American Society of Hematology (ASH) Annual Meeting

– Differentiated Syk/JAK Inhibitor Studied in Patients with Heavily Pre-Treated T-Cell Malignancies –        ...

author_avatar
NASDAQ Market News

Frontier Pharma Report 2017: Versatile Innovation in Immunology – Regulatory and Reimbursement Policy Shifts Favor First-in-Class Product Innovation

Dublin, Feb. 15, 2017 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition ...

author_avatar
NASDAQ Market News